晶泰科技(02228.HK) 宣布，与韩国药企JW Pharmaceutical签署千万级人民币的战略合作协议。晶泰科技将为JW部署一系列高通量自动化合成工站、AI反应条件优化系统及智能分析平台，以满足JW在自动化药物候选分子筛选、合成与工艺优化方向的复杂研发需求，期望以AI驱动药物发现。
晶泰科技表示，目前已与中石化(00386.HK) 、复旦大学、中医药广东省实验室等多领域标杆客户签订自动化实验室系统的购买合同，并完成现场交付，此次与JW的合作则是晶泰科技自动化实验室解决方案首次获海外药企客户采购。(gc/w)(港股报价延迟最少十五分钟。沽空资料截至 2025-02-03 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.